Tagged coronary-artery-disease

Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
Press Release

Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)

 Read More
Prolocor and Slingshot Biosciences Announce Publication of 'Assessing Prognosis by Quantifying FcγRIIa on Fixed Platelets' in Bioanalysis
Press Release

Prolocor and Slingshot Biosciences Announce Publication of 'Assessing Prognosis by Quantifying FcγRIIa on Fixed Platelets' in Bioanalysis

 Read More
Heparin Market Growth Predicted at Over 6.6% Through 2026: Global Market Insights, Inc.
Press Release

Heparin Market Growth Predicted at Over 6.6% Through 2026: Global Market Insights, Inc.

 Major heparin market players include Amphastar Pharmaceutical, Sanofi, Hepalink group, Pfizer, Leo Pharma, and Laboratorios Farmaceuticos Rovi SA. Read More
Press Release

Odessa's Healthy Heart Center Celebrates Ten Years of Helping Heart Patients Live Active, Symptom-Free Lives with the Assistance of Non-Invasive EECP® Therapy

 Healthy Heart's medical director, Dr. Suresh Gadasalli, says the painless treatment has reduced or eliminated angina pain, fatigue, and shortness of breath for hundreds of the center's patients Read More
Press Release

Advanced Heart Disease Patient Regains Lost Energy, Attends 50-Year Class Reunion After Receiving EECP® Therapy at Heart House in Washington Township

 Dr. Scott Fertels says non-invasive treatment boosts blood flow to the heart, relieves chest pain, and improves energy and mobility for about 80 percent of patients with symptomatic coronary artery disease Read More
Press Release

Glendale Heart Patient Trades Angina Pain and Shortness of Breath for Long Walks on the Beach After EECP® Therapy

 New, Non-invasive Outpatient Procedure for Treating Heart Disease Available at the Office of Dr. Don W. Lee Improves Vascular Health and can Reduce Symptoms Associated with Coronary Artery Disease for Three to Five Years Read More
Press Release

Neograft Technologies, Inc. Closes $5 Million Equity Offering

 Neograft Technologies, Inc., a medical device company developing advanced cardiac technologies for use in heart bypass procedures, announced successful completion of a $5 Million equity offering on July 29, 2011. Read More